Korean biotech leaders Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
03:19
Jan 12
Jan 12
Korean biotech leaders may outperform
Korean biotech market-cap leaders can be a useful leveraged strategy if KOSDAQ improves, especially around the JP Morgan Healthcare Conference and policy support.
MED
About Korean biotech leaders Investor Commentary
Across the available history and selected sources, Buzzberg tracks Korean biotech leaders across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Na Jeong-hwan.